ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014

Kennedy Bills Would Raise Salaries, Restore Construction, Expand Biomedical Research Support

July 14, 1989

Breast Density As Important As Age In Determining Risk

September 29, 2006

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

Another Flat Budget For NIH And NCI Despite Strong Bipartisan Support.

January 11, 2008

Three Genetics Pioneers Win Nobel Prize

October 11, 2002